Loading
For choices where the right answer depends on what the patient values (watching a slow prostate cancer, adjuvant chemo at 80, breast reconstruction), a tested decision aid becomes part of the consultation.
Decision aids improve knowledge, accuracy of risk perception and value-concordant choices in Cochrane reviews, yet are rarely used. The proposal is that guideline bodies designate a list of preference-sensitive decisions, that decision aids meeting IPDAS standards are certified for each, and that use is documented and audited like consent. A shared decision quality metric (knowledge plus concordance between stated values and chosen option) becomes a quality indicator.
Shares Patients lack understanding, navigation and agency, Prostate cancer.
Shares Patients lack understanding, navigation and agency, HR-positive / HER2-negative breast cancer, Prostate cancer.
Shares Overdiagnosis and false alarms, Patients lack understanding, navigation and agency, Prostate cancer.
Shares Overdiagnosis and false alarms, HR-positive / HER2-negative breast cancer.
Shares Overdiagnosis and false alarms, Patients lack understanding, navigation and agency.
Shares Overdiagnosis and false alarms, HR-positive / HER2-negative breast cancer.
Shares Overdiagnosis and false alarms, HR-positive / HER2-negative breast cancer.